These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30580432)

  • 21. The influence of hypoxic physical activity on cfDNA as a new marker of vascular inflammation.
    Pokrywka A; Zembron-Lacny A; Baldy-Chudzik K; Orysiak J; Sitkowski D; Banach M
    Arch Med Sci; 2015 Dec; 11(6):1156-63. PubMed ID: 26788076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endotheliopathy is associated with higher levels of cell-free DNA following major trauma: A prospective observational study.
    Naumann DN; Hazeldine J; Dinsdale RJ; Bishop JR; Midwinter MJ; Harrison P; Hutchings SD; Lord JM
    PLoS One; 2017; 12(12):e0189870. PubMed ID: 29261771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determining prognosis in canine sepsis by bedside measurement of cell-free DNA and nucleosomes.
    Letendre JA; Goggs R
    J Vet Emerg Crit Care (San Antonio); 2018 Nov; 28(6):503-511. PubMed ID: 30299568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating free DNA integrity and concentration as independent prognostic markers in metastatic breast cancer.
    Cheng J; Holland-Letz T; Wallwiener M; Surowy H; Cuk K; Schott S; Trumpp A; Pantel K; Sohn C; Schneeweiss A; Burwinkel B
    Breast Cancer Res Treat; 2018 May; 169(1):69-82. PubMed ID: 29340881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute effects of strength exercises and effects of regular strength training on cell free DNA concentrations in blood plasma.
    Tug S; Tross AK; Hegen P; Neuberger EWI; Helmig S; Schöllhorn W; Simon P
    PLoS One; 2017; 12(9):e0184668. PubMed ID: 28910365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients.
    Valpione S; Gremel G; Mundra P; Middlehurst P; Galvani E; Girotti MR; Lee RJ; Garner G; Dhomen N; Lorigan PC; Marais R
    Eur J Cancer; 2018 Jan; 88():1-9. PubMed ID: 29175734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring liver damage using hepatocyte-specific methylation markers in cell-free circulating DNA.
    Lehmann-Werman R; Magenheim J; Moss J; Neiman D; Abraham O; Piyanzin S; Zemmour H; Fox I; Dor T; Grompe M; Landesberg G; Loza BL; Shaked A; Olthoff K; Glaser B; Shemer R; Dor Y
    JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating cell-free DNA fragment analysis by microchip electrophoresis and its relationship with DNase I in cardiac diseases.
    Fujihara J; Takinami Y; Ueki M; Kimura-Kataoka K; Yasuda T; Takeshita H
    Clin Chim Acta; 2019 Oct; 497():61-66. PubMed ID: 31302100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic value of circulating cell-free DNA levels for hepatocellular carcinoma.
    Yan L; Chen Y; Zhou J; Zhao H; Zhang H; Wang G
    Int J Infect Dis; 2018 Feb; 67():92-97. PubMed ID: 29229500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High levels of circulating cell-free DNA are a biomarker of active SLE.
    Xu Y; Song Y; Chang J; Zhou X; Qi Q; Tian X; Li M; Zeng X; Xu M; Zhang W; Cram DS; Liu J
    Eur J Clin Invest; 2018 Nov; 48(11):e13015. PubMed ID: 30079480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative analysis of 12 different kits for bisulfite conversion of circulating cell-free DNA.
    Worm Ørntoft MB; Jensen SØ; Hansen TB; Bramsen JB; Andersen CL
    Epigenetics; 2017 Aug; 12(8):626-636. PubMed ID: 28557629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of cell-free DNA plasma concentration with severity of non-alcoholic fatty liver disease.
    Karlas T; Weise L; Kuhn S; Krenzien F; Mehdorn M; Petroff D; Linder N; Schaudinn A; Busse H; Keim V; Pratschke J; Wiegand J; Splith K; Schmelzle M
    J Transl Med; 2017 May; 15(1):106. PubMed ID: 28521774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microfluidic-based solid phase extraction of cell free DNA.
    Campos CDM; Gamage SST; Jackson JM; Witek MA; Park DS; Murphy MC; Godwin AK; Soper SA
    Lab Chip; 2018 Nov; 18(22):3459-3470. PubMed ID: 30339164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Senescence, Necrosis, and Apoptosis Govern Circulating Cell-free DNA Release Kinetics.
    Rostami A; Lambie M; Yu CW; Stambolic V; Waldron JN; Bratman SV
    Cell Rep; 2020 Jun; 31(13):107830. PubMed ID: 32610131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood hormones as markers of training stress and overtraining.
    Urhausen A; Gabriel H; Kindermann W
    Sports Med; 1995 Oct; 20(4):251-76. PubMed ID: 8584849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-invasive detection of human cardiomyocyte death using methylation patterns of circulating DNA.
    Zemmour H; Planer D; Magenheim J; Moss J; Neiman D; Gilon D; Korach A; Glaser B; Shemer R; Landesberg G; Dor Y
    Nat Commun; 2018 Apr; 9(1):1443. PubMed ID: 29691397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-free DNA derived from cancer cells facilitates tumor malignancy through Toll-like receptor 9 signaling-triggered interleukin-8 secretion in colorectal cancer.
    Niu Z; Tang W; Liu T; Xu P; Zhu D; Ji M; Huang W; Ren L; Wei Y; Xu J
    Acta Biochim Biophys Sin (Shanghai); 2018 Oct; 50(10):1007-1017. PubMed ID: 30239551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-free fetal DNA analysis in maternal plasma as screening test for trisomies 21, 18 and 13 in twin pregnancy.
    Le Conte G; Letourneau A; Jani J; Kleinfinger P; Lohmann L; Costa JM; Benachi A
    Ultrasound Obstet Gynecol; 2018 Sep; 52(3):318-324. PubMed ID: 28833712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The diverse origins of circulating cell-free DNA in the human body: a critical re-evaluation of the literature.
    Aucamp J; Bronkhorst AJ; Badenhorst CPS; Pretorius PJ
    Biol Rev Camb Philos Soc; 2018 Aug; 93(3):1649-1683. PubMed ID: 29654714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer.
    Ai B; Liu H; Huang Y; Peng P
    Oncotarget; 2016 Jul; 7(28):44583-44595. PubMed ID: 27323821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.